Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Julius Mugwagwa"'
Publikováno v:
BMJ Global Health, Vol 6, Iss 6 (2021)
Externí odkaz:
https://doaj.org/article/a3f0a49578c745de9226fe7334a67734
Autor:
Yorokpa Joachim Doua, Hanneke Dominicus, Julius Mugwagwa, Suzelle Magalie Gombe, Jude Nwokike
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background This research reviewed major Clinical Trial Registries (CTRs) and assessed the availability of fields on quality assurance for approved medicines used as Investigational Medicinal Products (IMPs) in phase IV clinical trials. Metho
Externí odkaz:
https://doaj.org/article/079c53282d9e4e63b0694b223c22441a
Autor:
Sarah J. L. Edwards, Blessing Silaigwana, Danny Asogun, Julius Mugwagwa, Francine Ntoumi, Rashid Ansumana, Kevin Bardosh, Jennyfer Ambe
Publikováno v:
Developing World Bioethics.
The COVID-19 pandemic has reinforced the critical role of ethics and community engagement in designing and conducting clinical research during infectious disease outbreaks where no vaccine or treatment already exists. In reviewing current practices a
Publikováno v:
Technology in Society. 68:101804
Publikováno v:
Papaioannou, T, Watkins, A, Mugwagwa, J & Kale, D 2017, ' Politics of Innovation and Development: the Role of Industry Associations in Integrating Political, Bureaucratic, Industrial and Health Systems in India and South Africa ', Development Policy Review, vol. 36, no. 1 . https://doi.org/10.1111/dpr.12308
Integrating political, bureaucratic, industrial and healthcare systems has been a major challenge for politics of innovation and development policy in low and middle income countries. This challenge has so far been understood in terms of separate ind
Autor:
Jude Nwokike, Julius Mugwagwa, Yorokpa Joachim Doua, Hanneke Dominicus, Suzelle Magalie Gombe
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-6 (2019)
Trials
Trials
Background This research reviewed major Clinical Trial Registries (CTRs) and assessed the availability of fields on quality assurance for approved medicines used as Investigational Medicinal Products (IMPs) in phase IV clinical trials. Methods Two re
Health-industry linkages for local health:Reframing policies for African health system strengthening
Autor:
Julius Mugwagwa, Maureen Mackintosh, Mercy Karimi Njeru, Paula Tibandebage, Samuel Wangwe, Geoffrey Banda, Jires Tunguhole
Publikováno v:
Mackintosh, M, Mugwagwa, J, Banda, G, Tibandebage, P, Tungohole, J, Wangwe, S & Karimi Njeru, M 2018, ' Health-industry linkages for local health : Reframing policies for African health system strengthening ', Health Policy and Planning, vol. 33, no. 4, pp. 602-610 . https://doi.org/10.1093/heapol/czy022
Health Policy and Planning
Health Policy and Planning
The benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Sahara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7e1c774c72d3633f37d101d2e8ee31
https://hdl.handle.net/20.500.11820/bf0f98a6-7d85-447f-a2e3-ae0af7434d82
https://hdl.handle.net/20.500.11820/bf0f98a6-7d85-447f-a2e3-ae0af7434d82
Publikováno v:
Research Policy. 44:1407-1418
Developed over the past three decades, the national innovation system concept (NIS) has been widely used by both scholars and policy makers to explain how interactions between a set of distinct, nationally bounded institutions supports and facilitate
Autor:
Julius Mugwagwa
Publikováno v:
International Journal of Technology Management & Sustainable Development. 14:163-177
Publikováno v:
International Journal of Technology Management & Sustainable Development. 2014, Vol. 13 Issue 1, p37-52. 16p. 5 Charts.